▶ 調査レポート

輸血の世界市場:製品別、エンドユーザー別、地域別分析

• 英文タイトル:Global Blood Transfusion Market - Segmented by Product, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)

Mordor Intelligenceが調査・発行した産業分析レポートです。輸血の世界市場:製品別、エンドユーザー別、地域別分析 / Global Blood Transfusion Market - Segmented by Product, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023) / B-MOR-05103資料のイメージです。• レポートコード:B-MOR-05103
• 出版社/出版日:Mordor Intelligence / 2018年4月
• レポート形態:英文、PDF、112ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:Healthcare
• 販売価格(消費税別)
  Single User(1名様用)¥629,000 (USD4,250)▷ お問い合わせ
  Team User(7名様用)¥666,000 (USD4,500)▷ お問い合わせ
  Corporate User¥1,295,000 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、輸血の世界市場について調べ、輸血の世界規模、市場動向、市場環境、製品別分析、エンドユーザー別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・輸血の世界市場インサイト
・輸血の世界市場環境
・輸血の世界市場動向
・輸血の世界市場規模
・輸血の世界市場規模:製品別
・輸血の世界市場規模:エンドユーザー別
・輸血の世界市場:地域別市場規模・分析
・輸血の北米市場規模・予測
・輸血のアメリカ市場規模・予測
・輸血のヨーロッパ市場規模・予測
・輸血のアジア市場規模・予測
・輸血の日本市場規模・予測
・輸血の中国市場規模・予測
・輸血のインド市場規模・予測
・輸血の韓国市場規模・予測
・関連企業情報・競争状況

The global blood transfusion market is expected to witness a CAGR of 4.9% during the forecast period (2018-2023). The market is growing at a fast pace with the rise in accidental cases, the growing number of blood transfusion procedures, competition, and M&A activities.

Rising Accidents and Trauma Cases

Trauma is considered to be the foremost cause of death and approximately 1, 80,000 people die with trauma every year. Up to 45% of the polytrauma patients die as a result of circulatory shock from acute blood loss. The World Health Organization states that the burden of the diseases related to injuries are mostly the road traffic injuries, accidents, etc., and these accidents are expected to rise dramatically by the year 2020. Each year 1.25 million people die because of these road accidents and a large amount of blood is being lost which requires blood transfusion and ultimately leads to the growth of the market.
The other factors including the automation in blood processing equipment, the increase in the R&D initiatives for regenerative medicine, the increasing number of surgical procedures, and the rise in the number of blood disorders are also contributing to the growth of the market.

High Costs Associated with Handling of Blood

The blood supply for the transfusions is very limited as not only is the donor pool shrinking due to the aging population but also due to the stringent donor selection process, and this has ultimately increased the demand for blood transfusion. According to the American Association of Blood Banks, around 15 million units of the packed red blood cells are being transfused in the US, and around 85 million units are being transfused annually worldwide. Currently 1% of total hospital costs are attributed to blood transfusion, however, this may vary by disease and procedures. The high costs associated with the blood transfusion have restricted the growth of the blood transfusion market.
The other factors include stringent rules and regulations, like approvals needed for separation of blood components, limit the total number of end-users, thereby, reducing the market size.

North America Dominates the Market

Geographically, North America is expected to dominate the market, owing to its well-developed healthcare industry and a rise in the number of patient’s population requiring the blood. However, the Asia-Pacific region is also projected to grow at the highest growth rate due to the rising government initiatives for the improvement of the healthcare facilities and increase in the number of blood banks.

Major Players: ABBOTT, MACOPHARMA, BECTON DICKINSON, B. BRAUN MELSUNGEN AG, TERUMO MEDICAL CORPORATION, HAEMONETICS CORPORATION, FRESENIUS KABI AG, IMMUCOR, AND KIDDE-FENWAL INC., amongst others.

Reasons to Purchase this Report

• Current and future global blood transfusion market outlook in the developed and emerging markets
• Various perspectives of the market, with the help of Porter’s five forces analysis
• The segment expected to dominate the market
• The region expected to witness the fastest growth rate during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)

Customization of the Report

• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.

レポート目次

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Rising Accidents and Trauma Cases
6.1.2 Increasing Number of Surgical Procedures
6.1.3 Increase in R&D Initiatives for Regenerative Medicine
6.1.4 Automation in Blood Processing Equipment
6.1.5 Rise in the Number of Blood Disorders
6.2 Market Restraints
6.2.1 High Costs Associated with Handling of Blood and its Components
6.2.2 Strict Approval Process and Regulations
6.3 Opportunities
6.4 Key challenges
7. Market Segmentation
7.1 -By Product
7.1.1 Blood Bag and Accessory
7.1.2 Blood Mixer
7.1.3 Fridge and Freezer
7.1.4 Filter
7.1.4.1 Inline Filter
7.1.4.2 Dockable Filter
7.1.5 Blood Component Separator
7.1.6 Apheresis Device
7.1.7 Pathogen Reduction System
7.1.8 Consumables and Supplies
7.1.9 Others
7.2 -By End User
7.2.1 Hospital
7.2.2 Ambulatory Surgical Centers
7.2.3 Blood Bank
7.2.4 Laboratory
7.2.5 Others
7.3 -By Geography
7.3.1 North America
7.3.1.1 United states
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 France
7.3.2.2 Germany
7.3.2.3 United kingdom
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest of Europe
7.3.3 Asia-Pacific
7.3.3.1 China
7.3.3.2 Japan
7.3.3.3 India
7.3.3.4 Australia & New Zealand
7.3.3.5 South Korea
7.3.3.6 Rest of Asia-Pacific
7.3.4 Middle East & Africa
7.3.4.1 GCC
7.3.4.2 South Africa
7.3.4.3 Rest of the Middle East & Africa
7.3.5 South America
7.3.5.1 Brazil
7.3.5.2 Argentina
7.3.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Abbott
9.2 Macopharma
9.3 Becton Dickinson
9.4 B. Braun Melsungen AG
9.5 Terumo Medical Corporation
9.6 Haemonetics Corporation
9.7 Fresenius Kabi AG
9.8 Immucor
9.9 Kidde-Fenwal Inc.
9.10 Others
9.11 List not Exhaustive
10. Future of the Market